Success Metrics

Clinical Success Rate
25.0%

Based on 1 completed trials

Completion Rate
25%(1/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
3(75%)

Phase Distribution

Ph phase_3
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution1 total trials
Phase 3Large-scale testing
1(100.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

25.0%

1 of 4 finished

Non-Completion Rate

75.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(1)
Terminated(3)

Detailed Status

Terminated3
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
25.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (100.0%)

Trials by Status

terminated375%
completed125%

Recent Activity

0 active trials
Showing 4 of 4
terminated

GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study

NCT00595296
terminated

GeneSearch Breast Lymph Node (BLN) Assay Timing Study

NCT00595023
completed

Validation Study Using the GeneSearch BLN Assay to Test Sentinel Lymph Nodes From Patients With Breast Cancer

NCT00551278
terminatedphase_3

GeneSearch™ Breast Lymph Node (BLN) Assay China Registration Study

NCT00869674

Clinical Trials (4)

Showing 4 of 4 trials
NCT00595296

GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study

Terminated
NCT00595023

GeneSearch Breast Lymph Node (BLN) Assay Timing Study

Terminated
NCT00551278

Validation Study Using the GeneSearch BLN Assay to Test Sentinel Lymph Nodes From Patients With Breast Cancer

Completed
NCT00869674Phase 3

GeneSearch™ Breast Lymph Node (BLN) Assay China Registration Study

Terminated

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4